4
as ethinyl estradiol and genistein (Mandrup et al., 2012; Mandrup et al., 2015; Cotroneo et al., 2002) . These findings 28 may predict adverse effects on human breast development and possibly increased risk of breast cancer following early 29 exposure to estrogenic chemicals . Animal studies have shown that developmental exposure to 30 endocrine disrupting compounds, or elevated perinatal levels of estrogens, can induce atypical hyperplasia of the 31 prostatic epithelium, as well as morphological changes resembling those of precancerous lesions in humans (PIN 32 lesions) (Prins et al., 2007) . 33
Due to the endocrine disrupting activity of butylparaben, a possible influence on prostate and mammary development 34
can be hypothesized, and hence this study aimed to investigate developmental effects of butylparaben on these organs in 35 prepubertal and adult offspring. We also intended to improve risk assessment of butylparaben by investigating 36 endocrine sensitive endpoints in perinatally exposed rats at doses from 10 mg/kg bw/day, and to elucidate the 37 mechanisms underpinning the influence of butylparaben on sperm count. 38
Materials and methods 39
Test compounds 40
Butylparaben (purity >99.0 %, CAS no. 94-26-8) was purchased from Sigma-Aldrich (Brøndby, Denmark). Corn oil 41 was used both as a control compound and vehicle and purchased from Sigma (Brøndby, Denmark). 42 Animals and exposure 43 72 time-mated nulliparous, young adult Wistar rats (HanTac:WH, SPF, Taconic Europe, Ejby, Denmark) were supplied 44 at day 3 of pregnancy. The day when a vaginal plug was detectable was designated as gestation day (GD) 1 and the 45 expected day of delivery, GD 23 was designated as pup day (PD) 1. The study was performed in 2 blocks of 36 dams 46 (separated by one week), and all dose groups were equally represented in both blocks. The animal experiment was 47 carried out at the DTU National Food Institute (Mørkhøj, Denmark). Ethical approval was obtained from the Danish 48 Pubertal onset was assessed by determining day of vaginal opening or the day of balano-preputial separation in weaned 80 female and male offspring, respectively. Registrations were performed daily in females from PD 27 until vaginal 81 opening was detected in all animals. Males were examined daily from PD 39 until the last male was positive. Age and 82 body weight of the rats were recorded on the day in which vaginal opening and balano-preputial separation was first 83 observed. Onset of puberty was assessed blinded with respect to exposure groups by skilled technicians. 84 85
Necropsy of male and female offspring PD 16/17 and 22 86
Reproductive organ weights and histological and gene expression changes in reproductive organ weights were 87 examined at PD 16 (males) and 17 (females), as this age has proved sensitive for detection of particularly anti-88 androgenic effects of chemicals (Metzdorff et al., 2007; Christiansen et al., 2009 ). On PD 16 and 17, one male and one 89 female pup from each litter (n=12-18) were weighed and decapitated, and blood was collected in heparinized tubes for 90 hormone analysis. From males the following organs were excised and weighed: Testes, ventral prostate, epididymis, 91 seminal vesicle, levator ani/bulbocavernosus muscle (LABC), bulbourethral gland, liver, adrenal, and retroperitoneal fat 92 pad. From females the following organs were excised and weighed: Ovary, liver, thyroid, and retroperitoneal fat pad. 93
One testis per pup was placed in RNAlater for gene expression studies as described below). 94
On PD 22, one female and one male pup per litter (n=12-14) were weighed and decapitated, and blood was collected in 95 heparinized tubes for hormone analysis. From females, ovaries were excised and weighed, and from males testes and 96 ventral prostate were excised and weighed. Testes were fixed in Bouin's fixative overnight and ventral prostates were 97 fixed in formalin for histological examination. Mammary glands were dissected from female pups for whole mounting. 98
The tissue was dissected in order to include the abdominal (4 th ) mammary gland with the adjacent lymph nodes and part 99 of the inguinal (5 th ) mammary gland. At PD 22 the number of terminal end buds (TEBs) in rat mammary glands is 100 peaking, and this age is considered sensitive to detection of changes in early mammary development (Russo et al., 101 1979; Mandrup et al., 2012) . 102
Necropsy of adults and epididymal sperm count 103
Approximately one female and one male pup per litter were sacrificed at PD 80 to 90 and body weights were 104 determined. From males the following organs were excised and weighed: Testes, epididymis, seminal vesicle with 105 prostate, ventral prostate (separated from dorsolateral prostate and seminal vesicle) levator ani/bulbocavernosus muscle, 106 bulbourethral gland, liver, thyroid, 4 th mammary gland, and retroperitoneal fat pad. One testis per animal was fixed in 107 at DTU Library on April 28, 2016 http://toxsci.oxfordjournals.org/
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Bouin's fixative overnight, and the contralateral was frozen for gene expression studies. Epididymides, ventral prostates 108 and mammary glands were fixed in formalin for histological examination. 109
For sperm count analysis, samples were analyzed using computer assisted sperm analysis (CASA) system (HTM-IVOS, 110
Hamilton Thorne Research, MA, USA). From male offspring, alternately left or right cauda epididymis including 1 cm 111 of ductus deferens was frozen in liquid nitrogen and stored at -80°C for sperm count analysis. The cauda epididymis 112 was thawed, weighed and prepared as described by Jarfelt et al. (2005) , and samples were analyzed using a 10 × UV 113 fluorescent objective and IDENT OPTIONS on the CASA. Ten fields were analyzed for each sample and three counts 114 were performed for each suspension. Counts were averaged and data are presented as number of sperm per gram cauda. 115
Sperm cell motility and morphology was not investigated. 116
Females were sacrificed on the day of estrous as judged from a vaginal smear in the morning. The following organs 117 were excised and weighed: Ovaries, uterus, liver, thyroid, mammary glands (4 th gland), and retroperitoneal fat pad. 118
Abdominal (4 th ) mammary glands, ovaries and uteri were fixed in formalin for histological examination. 119
Hormone analysis and gene expression 120
Serum estradiol was measured in 8 to 10 plasma samples per dose group in PD 16 males and PD 22 females using 121
Enzyme Linked Assay (Cayman kit no. 582251, Bertinpharma, Montigny-le-Bretonneux, France). 122
Gene expression analyses were performed on testes PD 16 (n=9-10) and PD 90 (n=4) by RT-qPCR. Protocols and 123 verification of suitable reference genes for data normalization were as previously described (Svingen et al., 2015) . 124
Briefly, total RNA was extracted from the entire testis at PD16 or approximately 120 mg tissue (median cross-section) 125 at PD90 using an RNA Mini kit (Qiagen), including on-column DNAse I treatment. RNA was subsequently quantified 126 and purity-verified on a nano-drop spectrophotometer and 500 ng total RNA used to synthesize cDNA (Omiscript kit; Cybernetics, Bethesda, MD, USA). The glands were evaluated for outgrowth and extent of mammary development. For 140 each dose group, 12 to 14 samples were evaluated. Outgrowth was assessed by measuring the outer area, longitudinal 141 growth, transverse growth, distance to the lymph node (shortest distance from the 4 th gland to the adjacent lymph node) 142 and distance to the 5 th gland (shortest distance from the 4 th to the 5 th abdominal mammary gland). The number of 143 terminal end buds was counted (TEBs, defined as tear-drop shaped buds in zone C with a diameter of 100 µm or more, 144
as defined by Russo and Russo, 1996a) . 145 146
Histological examination 147
Female mammary glands PD 80-90 were sectioned and stained with haematoxylin and eosin by standard procedures. 148
Histologic evaluation included ductular changes, lobular changes and functional changes in females confirmed to be in 149 oestrous. Ductular changes included the evaluation and distribution of intraductal hyperplasia (defined as duct 150 epithelium with 3 or more layers of epithelial cells as described by Singh et al., 2000) . Evaluation of lobular changes 151 included lobule types (as single alveoli/ lobules smaller than type 1, lobules type 1 or lobules type 2 as defined by 152
Russo et al., 1996a for humans) and lobuloalveolar structure of the lobules (loss of the typical tubuloalveolar 153 architecture of alveoli). Finally, the distribution of secretory material in the ducts was evaluated as a sign of secretory 154
activity. 155
Ovary histology was examined in one section from all adult females from the control and high dose groups and focused 156 only on health status and cyclic activity. No quantitative measures were made. Uterine histology was examined only to 157 confirm estrous cycle stage to aid the histological examination of mammary glands. 158
Histological examination of one section per organ (testes, epididymides and ventral prostate) was performed in all adult 159 males from the high dose and control groups. A detailed qualitative examination of the testes was performed taking into 160 account the tubular stages of the spermatogenic cycle to identify effects such as missing germ cell layers or types, 161 retained spermatids, multinucleate or apoptotic germ cells and sloughing of spermatogenic cells into the lumen. 162
Epididymides were evaluated for ductal atrophy, changes in sperm content and presence of sloughed testicular germ 163 cells and cell debris in the epididymal lumen. Ventral prostates of adult males were evaluated with regard to degree of 164 inflammation, epithelial atrophy, and atypical hyperplasia. Additionally, morphometric examination was made in 165 ventral prostate from adult and prepubertal (PD 22) males to identify possible changes in the relative areas of different 166 compartments. Each area was applied a grid with 15 points that were manually assigned as epithelium, stroma, lumen or 167 outside tissue section/undefined. This was done in 10 randomly selected areas per tissue section under 20x or 10x 168 magnification (PD 22 and 90, respectively) using Image-Pro1 Plus ver. 7.0 (Media Cybernetics, Inc., USA). The 169 percentage of areas occupied by each compartment (epithelium, stroma, and lumen) was compared between exposed 170 groups and controls, and the ratio between epithelium and lumen was calculated and compared between groups. Grid 171 points outside the tissue or undefined were not included in the statistical analysis. covariate. When more than one pup from each litter was examined, statistical analyses were adjusted using litter as an 180 independent, random and nested factor in ANOVA or litter means were used. In cases where normal distribution and 181 homogeneity of variance could not be obtained by data transformation (i.e. whole mount measurements), a non-182
parametric Kruskall-Wallis test was applied followed by Dunn's multiple comparison test comparing exposed groups 183 with controls. 184 10 AGD and organ weights were analyzed using body weight as a covariate. The number of nipple/areolas was assumed to 185 follow a binomial distribution with a response range between 0 and θmax, with θmax being equal to the biologically 186 possible maximal number of nipples in rats, either 12 or 13. The choice of θmax was decided on considering the global 187 fit (information criterion of Schwarz). To account for litter effects on nipple retention, correlation structures between 188 number of nipple/areolas and litter were modelled by the Generalized Estimating Equations method using the SAS 189 procedure PROC GENMOD. 190
Histological scoring data were evaluated using the 2x2 Fisher's Exact Test without correction for multiple comparisons. 191
Results 192

Dams and delivery 193
Exposure to butylparaben did not affect maternal body weight gain, gestation length, litter size, pre-or perinatal 194 offspring survival, or body weights either at birth or in the postnatal period (Table 1) . 195
In vivo markers of endocrine disrupting effects 196
Endocrine-disrupting effects of butylparaben were seen in neonatal pups, as AGD (analyzed with body weight as a 197 covariate) was reduced dose-dependently in both males and females at PD 1 following perinatal exposure to 100 or 500 198 mg/kg bw/day ( Fig. 1 and Table 1 ). No significant effects were seen for male nipple retention (Table 1) . 199
Sexual maturation, measured as day of vaginal opening (VO) in females and day of preputial separation (PPS) in males 200 occurred slightly later in both male and female offspring exposed to butylparaben, but this was not statistically 201 significant (Table 1) . 202
Organ weights, epididymal sperm counts and histology 203
No effects of butylparaben on the body weight of offspring were seen on PD 16, 17, 22 or in adulthood. In male 204 offspring, no changes in reproductive organ weights were detected at PD 16 or 22 (Table 2 ). In female offspring, ovary 205 weights were reduced dose-dependently at PD 17, and the effect was statistically significant at 100 and 500 mg/kg 206 bw/day ( Fig. 1 ; Table 2 ). Ovary weights were slightly higher compared to controls at PD 22, but this was not 207 statistically significant (p=0.086 at high dose) ( Table 2) . 208
In adult males (PD 90), the weight of prostate and seminal vesicle (together) and the weight of ventral prostate 209 (separated from seminal vesicle) were reduced in the highest dose group compared to controls (p=0.015 and p=0.05, 210 respectively) ( Fig. 1 ; Table 2 ). Epididymal weight was significantly increased in the middle dose group only (p=0.01) 211 (Table 2) , and epididymal sperm count was significantly decreased in all dosed groups compared to the controls (p < 212 0.0001) (Fig. 3) .The histological examination of testes and epididymides from adult controls and high dose males 213 showed no differences between groups. 214
No other effects were seen on adult male or female organ weights (Table 2) . 215
Testicular gene expression 216
At PD 16, Cyp19a1 expression was significantly lower in testes from all exposure groups compared to controls ( Fig.  217   2a ). There was a tendency towards highest levels of exposure showing lowest level of expression; relative mRNA levels 218 were 33%, 30% and 23% that of control group for 10, 100 and 500 mg/kg bw/day groups, respectively. Expression level 219 of several cell-specific marker genes was unchanged at PD16 following exposure to butylparaben. The germ cell marker 220
Ddx4 was unchanged in all groups, suggesting that germ cell numbers were unchanged (Fig. 2a ). The Sertoli cell 221 markers Sox9 and Fshr showed stable expression across groups, indicating that, at least Sertoli cell numbers were 222 unaffected by exposure ( Fig. 2a ). So too, the Sertoli/Leydig cell marker Nr5a1 and Ar were unchanged, as were all the 223 Leydig cell markers Lhr, Cyp11a1, Cyp17a1 and Hsd3b1 (Fig. 2a) . 224
In adult testes, Cyp19a1 expression was similar in exposed and control animals. All other marker genes were also 225 unchanged except Nr5a1, which was lower than controls in all exposed groups (Fig. 2b) . 226
Histological examination of prostate 227
In ventral prostates of prepubertal males, morphometric analysis showed that the epithelial area ( Fig. 4A ) and the ratio 228 between epithelium and lumen ( Fig. 4B) were decreased in the middle dose group compared to controls. At this age, 229 most prostates had small acini with columnar epithelium and an abundant amount of secretory material in the apical part 230 of the cells (Fig. 4C ), whereas animals with a low ratio between epithelium and lumen had an increased incidence of 231 large acini with cuboidal epithelium (Fig. 4D) . 232
Adult ventral prostate histology differed markedly between individuals, but this was not dose related. Several animals 233 showed variable degree of inflammation in the ventral prostate, consisting of focal or diffuse accumulation of 234 12 mononuclear cells. We observed no difference between groups in total numbers of animals with interstitial 235 inflammation (5 out of 16 controls and 7 out of 18 high dose animals), nor between groups in scores for degree of 236 inflammation (data not shown). In some cases, the epithelium adjacent to inflammatory foci showed minor reactive 237 hyperplasia with cellular atypia (4 out of 16 controls and 6 out of 18 high dose animals). There was no difference 238 between groups in scores for epithelial height, and morphometric analysis of the ratio between luminal area and 239 epithelial area showed no differences between dose groups at PD 90 (data not shown). 240
Dorsolateral prostate showed a much lower incidence of inflammatory foci than ventral prostate, with small 241 inflammatory foci only seen in 2 controls and 1 high dose animal. Dark granules in epithelial cell cytoplasm or nuclei 242 were seen in several areas of dorsolateral prostate for some animals, but no difference in incidence was seen between 243 dose groups (7 out of 16 controls and 5 out of 18 high dose animals affected). 244
Mammary gland development and histology in female offspring 245
Prepubertal mammary glands were affected by perinatal exposure to butylparaben. At PD 22, female mammary glands 246 showed a significantly higher number of terminal end buds (TEBs) in the two highest dose groups compared to controls 247 ( Fig. 4F-H) . Indications of increased outgrowth towards the lymph node was seen, as the distance between mammary 248 tissue and lymph node was significantly reduced in females exposed to 100 mg/kg bw/day of butylparaben compared to 249 control females (Fig. 4E) . 250
No clear effect of butylparaben was seen on mammary glands of adult female offspring. However, more females 251 displayed delayed differentiation of the adult mammary glands and increased proliferation of duct epithelium in the 252 lowest dose group compared to controls, but this was not statistically significant. Five out of 13 females from the low 253 dose group had less developed lobules (lobules smaller than type 1) compared to 1 of 14 females from the control group 254 (p=0.08 in 2x2 Fisher). Three out of 13 females had intraductal hyperplasia (>30% of tissue) in the low dose group, 255 whereas no controls had intraductal hyperplasia (p=0.1 in 2x2 Fisher) ( Fig. 4I-J) . No sign of secretory activity or 256 changes in tubuloalveolar morphology of the lobules were observed. 257
Histological examination of ovaries 258
The histological examination of ovaries from adult controls and high dose females showed apparently healthy ovaries 259 with presence of all stages of follicles and with an abundant number of corpora lutea (data not shown). 260
Serum hormone levels 261
Serum estradiol levels were examined at PD 16 in males and at PD 22 in females, i.e. time points when we observed 262 effects that may be related to altered estradiol production (reduced aromatase gene expression in testes and increased 263 female mammary outgrowth). No effects of treatment were observed at these time points. 264
Discussion 265
Butylparaben is known to affect sperm count in rat offspring, but until now knowledge on other reproductive endpoints 266 has been lacking. In this study we found endocrine disrupting effects in both male and female offspring after perinatal 267 exposure of rats, including shortened AGD, reduced sperm count and reproductive organ weight, disrupted gene 268 expression in the testes, and abnormal mammary gland development. Of particular importance for risk assessment is the 269 observation that the sperm count was lower at all doses, starting at 10 mg/kg. 270
Mechanisms of actions for effects on the male reproductive system 271
We observed a reduction in epididymal sperm count, which corroborates previous findings in rat offspring following in the current study, although rat strain and study design were comparable. To some extent, our findings of effects at 276 relatively low oral doses are supported by a study showing reduced sperm count and motility in rats perinatally exposed 277 to 2.5 mg/kg bw/day of the structurally related isobutylparaben (Yang et al., 2015) . 278
In the current study, a shortened neonatal male AGD was seen from 100 mg/kg bw/day, but the same was only seen at 279 doses from 400 mg/kg bw/day of butylparaben in the study by Zhang et al., 2014, and not in the study by Kang et al., 280
2002 (see Table 3 ).In a previous study we showed that subcutaneous exposure of pregnant dams to 200 or 400 mg/kg 281 bw/day of butylparaben did not affect AGD or testicular testosterone synthesis in fetal male rats (Taxvig et al., 2008) . To gain further insight into potential mechanisms behind the effects on male reproductive development, we analyzed 290 the expression of several genes in prepubertal and adult testes. Several cell-specific marker genes were unchanged both 291 at PD16 and adulthood, suggesting that the general testis cellularity was maintained. However, at PD16 the expression 292 of Cyp19a1 (aromatase) was lower in all dose groups compared to controls. CYP19 catalyzes the conversion of 293 androgens into estrogens (Simpson et al., 2002) , and at this stage aromatase is expressed by immature rat Sertoli cells 294 and is stimulated by FSH to elevate serum estradiol for a few days (Picut et al., 2015) . The role of estradiol at this age is 295 not clear, but the increase in estradiol coincides with the first wave of spermatogenesis and establishment of the blood-296 testis barrier. Therefore, it may be speculated that the reduction of aromatase levels at this stage is related to the 297 observed low sperm count later in life. Alternatively, our findings may reflect a slight delay in development of the 298 exposed rats. Although butylparaben did not appear to affect estradiol synthesis or secretion at this age, it would be 299 interesting to further scrutinize possible effects of butylparaben on testicular aromatase levels and estradiol production. 300
In adult testes we observed a reduction in Nr5a1 expression in exposed animals. Nr5a1 encodes a nuclear receptor 301 commonly called Steroidogenic Factor-1 (SF-1), which is involved in the regulation of numerous genes, including showed a slightly lower expression in the same testes displaying reduced Nr5a1 levels, which is in line with the known 305 involvement of NR5A1 in the transcriptional regulation of several CYP genes, including Cyp17. Therefore, 306 butylparaben exposure could be suggested to compromise reproductive function by interfering with steroidogenesis. 307
However, butylparaben had no or limited effects on estradiol or testosterone levels adrenal H295R cells (Taxvig et al., 308 2008) . 309
The observed reduction in prostate and seminal vesicle weight in adult animals may also be a consequence of altered 310 hormone production early or late in life. Indications of early changes in prostate development were seen as the relative 311 epithelial area in PD 16 prostates was reduced at 100 mg/kg bw/day compared to controls, but we found no histological 312 changes in prostates of young adults after butylparaben exposure. It is well known that developmental exposure to other 313 estrogenic chemicals or elevated perinatal levels of estrogens in rodents can induce atypical hyperplasia of the prostatic 314
epithelium (PIN lesions) and morphological changes resembling those of precancerous lesions in humans (reviewed by 315
Prins et al., 2007). Focal proliferative effects are, however, unlikely to be reflected by prostate weights. But neonatal 316 exposure to high doses of estradiol benzoate in rats was found to induce prostatic PIN lesions and reduced dorsal 317 prostate weight later in life (Ho et al., 2006) . Therefore, despite being indicative, our data on prostate weights alone 318 does not allow us to conclude whether proliferative effects were induced by butylparaben or not, nor does it lend 319 enough insight to elucidate possible effects of parabens on prostate cancer susceptibility. For this, further examination 320 in older animals or in a cancer induction model is necessary. 321
Altered female reproductive development 322
The fact that prepubertal female rats exposed to butylparaben displayed increased outgrowth of mammary glands and a 323 (Russo et al., 1979; Russo and Russo, 1996b) , and a link 330 between chemically induced increases in TEB numbers and an increased risk of mammary cancer has been proposed 331 (Fenton, 2006) . In adult mammary gland, possible effects on intraductal hyperplasia and reduced lobular development 332
were observed at 10 mg/kg bw/day, but the low incidence of intraductal hyperplasia and the lack of effect at higher 333 doses complicate the interpretation of these findings. Interestingly, intraductal hyperplasia has also been observed at The observed reduction in prepubertal ovary weight is in agreement with a study on neonatal rats showing delayed 339 follicular recruitment at PD 8 after 7 days of subcutaneous exposure to propyl-and butylparaben (Ahn et al., 2012) . In 340 our study, adult ovaries appeared normal, but it may be speculated that a possible interference with early follicle 341 recruitment may have long-term adverse effects manifesting as altered reproductive function later in life. Currently, few 342 16 studies have targeted the influence of chemicals on early ovarian development. One example of altered early ovary 343 development with late-life consequences following exposure to a weak estrogen is the finding of inhibited germ cell 344 nest breakdown on PND 4 and an early decline in fertility in mice prenatally exposed to low doses of bisphenol a 345 (Wang et al., 2014) . 346
Few studies have reported changes in female AGD at birth, but we observed a slight reduction in female pup AGD 347 
Implications for risk assessment 354
We found that both prepubertal aromatase expression and adult sperm count were affected at the lowest administered 355 dose of butylparaben. This corresponds to the dose level previously shown to affect sperm count following juvenile 356 that this starting point for risk assessment was a "conservative choice". However, the current data suggest that a 362 NOAEL of 2 mg/kg bw/day is not conservative, as the observed reductions of epididymal sperm count and testicular 363 aromatase expression at 10 mg/kg bw/day points to a NOAEL at or possibly below 2 mg/kg bw/day. This is further 364 corroborated by the recent finding of reduced sperm count and motility in rats perinatally exposed to 2.5 mg/kg bw/day 365 of the structurally related isobutylparaben (Yang et al., 2015) . 366
The SCCS discussed that rats may be a poor model for assessing and extrapolating potential harmful effects of 367 butylparaben in humans, as rats have a much greater metabolic rate. For instance, internal exposure levels of free 368 parabens measured in human males exposed dermally to 10 mg/kg bw/day were similar to internal exposure of rats 369 exposed orally to 1000 mg/kg bw/day (Appendix 2 of SCCS 2013). Therefore, the SCCS noted that when using 370 toxicokinetic data, it is uncertain whether the desired margin of safety of 25 can be achieved and thus, that uncertainties 371 with risk assessment remain which presently cannot be resolved (SCCS 2013). Notably, blood levels of parabens do not 372 directly reflect levels in solid tissues. Examination of tissue distribution of C14-labelled butylparaben and metabolites 373 in rats showed higher tissue concentrations than in blood for oral, intravenous, as well as dermal exposure routes 374 (Mathews et al., 2013) . Furthermore, fetal exposure levels may exceed maternal blood levels (Frederiksen et al., 2008) . 375
Therefore, a concern remains that the developing human may not be sufficiently protected against some of the multiple 376 endocrine disrupting effects of butylparaben, either alone or in combination with other endocrine disrupting chemicals. 377
In summary, butylparaben altered AGD, ovary and prostate weights, sperm counts and mammary development, and 378 thus exerted endocrine disrupting effects on both male and female offspring. Interestingly, gene expression profiling of 379 testis indicated that some of the male reproductive effects may be related to changes in steroidogenesis. Table 2 . Body and organ weights in rat offspring following perinatal exposure to butylparaben. Asterisks indicate 497 statistically significant difference from control group. *: p<0.05, **: p<0.01, ***: p<0.001. Figure 1 . Morphological effects in butylparaben-exposed rats. A, B) Perinatal exposure to 100 or 500 mg/kg bw/day of butylparaben caused shortened AGD in both male and female offspring relative to control animals. C, D) Ovary weights were reduced at PD 17, but not at PD 22, following perinatal exposure to 100 or 500 mg/kg bw/day of butylparaben. E, F) The weights of ventral prostate, total seminal vesicle and prostate were reduced at PND 90 following perinatal exposure to 500 mg/kg bw/day of butylparaben. Mean+SEM. *: p<0.05, **: p<0.01, ***: p<0.001. AGD was analyzed with body weight as a covariate and litter as a random factor; organ weights were analyzed with body weight as a covariate. n=13-17 litters per dose group. 224x283mm (300 x 300 DPI) at DTU Library on April 28, 2016 http://toxsci.oxfordjournals.org/ Downloaded from Figure 2 . Relative gene expression levels in PD16 and PD 90 testes from control and butylparabene-exposed rats. A) At PD 16, relative expression levels of the germ cell marker Ddx4, Sertoli cell markers Sox9 and Fshr, the Sertoli/Leydig expressed genes Ar and Nr5a1, and Leydig cell markers Lhr, Cyp11a1, Cyp17a1 and Hsd3b11 were unchanged following exposure to 10, 100 or 500 mg/kg bw/day butylparaben. Expression of Cyp19a1 (aromatase) was significantly lower in testes from all exposure groups at PD 16. B) In adult testes, the expression of the same genes was unchanged except for Nr5a1, which was lower in testes from all exposed groups compared to controls. Relative expression levels are shown with mean value of control testes set to 1, with data normalized using the geometric mean of Rpl13a and Sdha (prepubertal, n=9-10; adult, n=4; Mean ± SEM; *p<0.05). 254x190mm (96 x 96 DPI) Figure 3 . Number of sperm per gram cauda in male rats exposed to 0; 10; 100 and 500 mg butylparaben/kg bw/day from GD 7 to PD 22. Group mean values ± SD are shown, n = 13-17. Sperm count is significantly lower, indicated by *** with p < 0.0001, in all dosed groups compared to the control group. 72x50mm (300 x 300 DPI)
at DTU Library on April 28, 2016 http://toxsci.oxfordjournals.org/ Downloaded from Figure 4 . Effects of perinatal butylparaben exposure of rats on early prostate and mammary gland development. A, B) Morphometric analysis revealed a reduced epithelial area (as a percentage of total prostate area) and reduced epithelium to lumen ratio in PD 22 male offspring from the middle dose group. Data represents group means +SEM, n=11-14. Asterisks indicate statistically significant differences from controls analyzed in ANOVA followed by Dunnett's test, *: p<0.05; **: p<0.01. C, D) Ventral prostate histology at PD 22, bars indicate 50 µm. Control animals (C) had columnar epithelium in ventral prostate, whereas enlarged acini with reduced epithelial height were seen mainly in the middle dose group (D). E) Outgrowth of female mammary glands, measured as the distance from the mammary gland to nearest lymph node, was increased in animals exposed to 100 mg/kg bw/day butylparaben. F) The number of terminal end buds in females was increased at 100 and 500 mg/kg bw/day. Data points indicate measurements from individual animals with lines representing group means. ** indicate a statistically significant difference from controls with p<0.01 analyzed by Kruskal-Wallis' nonparametric test followed by Dunn's post test for multiple comparisons. N=12-14. G) Representative mammary whole mount image of a 
